CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Torrent Pharma Inc. recalls Fluoxetine Tablets

Read the official FDA notice

Published
11 Jun 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister)

Fluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-30

Brand / company
Torrent Pharma Inc.
Codes / lots
Lot# BDX6K001; Exp. Date: 06/30/2025 | Lot# BDX6K001; Exp. Date 06/30/2025
Distribution
U.S. Nationwide.
Recall status
Completed

Source: U.S. Food and Drug Administration, published 11 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.